Search

Background and objectives: This review aims to delve into the role of artificial intelligence in medicine. Ulcerative colitis (UC) is a chronic, inflammatory bowel disease (IBD) characterized by superficial mucosal inflammation, rectal bleeding, diarrhoea and abdominal pain. By identifying the challenges inherent in UC diagnosis, we seek to highlight the potential impact of artificial intelligence on enhancing both diagnosis and treatment methodologies for this condition. Method: A targeted, non-systematic review of literature relating to ulcerative colitis was undertaken. The PubMed and Scopus databases were searched to categorize a well-rounded understanding of the field of artificial intelligence and its developing role in the diagnosis and treatment of ulcerative colitis. Articles that were thought to be relevant were included. This paper only included articles published in English. Results: Artificial intelligence (AI) refers to computer algorithms capable of learning, problem solving and decision-making. Throughout our review, we highlighted the role and importance of artificial intelligence in modern medicine, emphasizing its role in diagnosis through AI-assisted endoscopies and histology analysis and its enhancements in the treatment of ulcerative colitis. Despite these advances, AI is still hindered due to its current lack of adaptability to real-world scenarios and its difficulty in widespread data availability, which hinders the growth of AI-led data analysis. Conclusions: When considering the potential of artificial intelligence, its ability to enhance patient care from a diagnostic and therapeutic perspective shows signs of promise. For the true utilization of artificial intelligence, some roadblocks must be addressed. The datasets available to AI may not truly reflect the real-world, which would prevent its impact in all clinical scenarios when dealing with a spectrum of patients with different backgrounds and presenting factors. Considering this, the shift in medical diagnostics and therapeutics is coinciding with evolving technology. With a continuous advancement in artificial intelligence programming and a perpetual surge in patient datasets, these networks can be further enhanced and supplemented with a greater cohort, enabling better outcomes and prediction models for the future of modern medicine. [ABSTRACT FROM AUTHOR]

Parkinson's disease (PD) is a serious movement disorder that may eventually progress to mild cognitive dysfunction (MCI) and dementia. According to the Parkinson's foundation, one million Americans were diagnosed with PD and almost 10 million individuals suffer from the disease worldwide. An early and precise clinical diagnosis of PD will ensure an early initiation of effective therapeutic treatments, which will potentially slow down the progression of the disease and improve the quality of life for patients and their caregivers. Machine and deep learning are promising technologies that may assist and support clinicians in providing an objective and reliable diagnosis of the disease based upon significant and unique features identified from relevant medical data. In this paper, the author provides a comprehensive review of the artificial intelligence techniques that were recently proposed during the period from 2016 to 2022 for the screening and staging of PD as well as the identification of the biomarkers of the disease based on Electroencephalography (EEG), Magnetic Resonance Imaging (MRI), speech tests, handwriting exams, and sensory data. In addition, the author highlights the current and future trends for PD diagnosis based machine and deep learning and discusses the limitations, challenges, potential future solutions, and recommendations for a reliable application of machine and deep learning for PD detection and screening. [ABSTRACT FROM AUTHOR]

Malaria is predominant in many subtropical nations with little health-monitoring infrastructure. To forecast malaria and condense the disease's impact on the population, time series prediction models are necessary. The conventional technique of detecting malaria disease is for certified technicians to examine blood smears visually for parasite-infected RBC (red blood cells) underneath a microscope. This procedure is ineffective, and the diagnosis depends on the individual performing the test and his/her experience. Automatic image identification systems based on machine learning have previously been used to diagnose malaria blood smears. However, so far, the practical performance has been insufficient. In this paper, we have made a performance analysis of deep learning algorithms in the diagnosis of malaria disease. We have used Neural Network models like CNN, MobileNetV2, and ResNet50 to perform this analysis. The dataset was extracted from the National Institutes of Health (NIH) website and consisted of 27,558 photos, including 13,780 parasitized cell images and 13,778 uninfected cell images. In conclusion, the MobileNetV2 model outperformed by achieving an accuracy rate of 97.06% for better disease detection. Also, other metrics like training and testing loss, precision, recall, fi-score, and ROC curve were calculated to validate the considered models. [ABSTRACT FROM AUTHOR]

Degenerative nerve diseases such as Alzheimer's and Parkinson's diseases have always been a global issue of concern. Approximately 1/6th of the world's population suffers from these disorders, yet there are no definitive solutions to cure these diseases after the symptoms set in. The best way to treat these disorders is to detect them at an earlier stage. Many of these diseases are genetic; this enables machine learning algorithms to give inferences based on the patient's medical records and history. Machine learning algorithms such as deep neural networks are also critical for the early identification of degenerative nerve diseases. The significant applications of machine learning and deep learning in early diagnosis and establishing potential therapies for degenerative nerve diseases have motivated us to work on this review paper. Through this review, we covered various machine learning and deep learning algorithms and their application in the diagnosis of degenerative nerve diseases, such as Alzheimer's disease and Parkinson's disease. Furthermore, we also included the recent advancements in each of these models, which improved their capabilities for classifying degenerative nerve diseases. The limitations of each of these methods are also discussed. In the conclusion, we mention open research challenges and various alternative technologies, such as virtual reality and Big data analytics, which can be useful for the diagnosis of degenerative nerve diseases. [ABSTRACT FROM AUTHOR]

Featured Application: Medical diagnosis and computer-aided diagnosis systems. Breast cancer is one of the most common types of cancer among women. Accurate diagnosis at an early stage can reduce the mortality associated with this disease. Governments and health organizations stress the importance of early detection of breast cancer as it is related to an increase in the number of available treatment options and increased survival. Early detection gives patients the best chance of receiving effective treatment. Different types of images and imaging modalities are used in the detection and diagnosis of breast cancer. One of the imaging types is "infrared thermal" breast imaging, where a screening instrument is used to measure the temperature distribution of breast tissue. Although it has not been used often, compared to mammograms, it showed promising results when used for early detection. It also has many advantages as it is non-invasive, safe, painless, and inexpensive. The literature has indicated that the use of thermal images with deep neural networks improves the accuracy of early diagnosis of breast malformation. Therefore, in this paper, we aim to investigate to what extent convolutional neural networks (CNNs) with attention mechanisms (AMs) can provide satisfactory detection results in thermal breast cancer images. We present a model for breast cancer detection based on deep neural networks with AMs using thermal images from the Database for Research Mastology with Infrared Image (DMR-IR). The model will be evaluated in terms of accuracy, sensitivity and specificity, and will be compared against state-of-the-art breast cancer detection methods. The AMs with the CNN model achieved encouraging test accuracy rates of 99.46%, 99.37%, and 99.30% on the breast thermal dataset. The test accuracy of CNNs without AMs was 92.32%, whereas CNNs with AMs achieved an improvement in accuracy of 7%. Moreover, the proposed models outperformed previous models that were reviewed in the literature. [ABSTRACT FROM AUTHOR]

Background: Machine learning (ML) is a key component of artificial intelligence (AI). The terms machine learning, artificial intelligence, and deep learning are erroneously used interchangeably as they appear as monolithic nebulous entities. This technology offers immense possibilities and opportunities to advance diagnostics in the field of medicine and dentistry. This necessitates a deep understanding of AI and its essential components, such as machine learning (ML), artificial neural networks (ANN), and deep learning (DP). Aim: This review aims to enlighten clinicians regarding AI and its applications in the diagnosis of oral diseases, along with the prospects and challenges involved. Review results: AI has been used in the diagnosis of various oral diseases, such as dental caries, maxillary sinus diseases, periodontal diseases, salivary gland diseases, TMJ disorders, and oral cancer through clinical data and diagnostic images. Larger data sets would enable AI to predict the occurrence of precancerous conditions. They can aid in population-wide surveillance and decide on referrals to specialists. AI can efficiently detect microfeatures beyond the human eye and augment its predictive power in critical diagnosis. Conclusion: Although studies have recognized the benefit of AI, the use of artificial intelligence and machine learning has not been integrated into routine dentistry. AI is still in the research phase. The coming decade will see immense changes in diagnosis and healthcare built on the back of this research. Clinical significance: This paper reviews the various applications of AI in dentistry and illuminates the shortcomings faced while dealing with AI research and suggests ways to tackle them. Overcoming these pitfalls will aid in integrating AI seamlessly into dentistry. [ABSTRACT FROM AUTHOR]

Globally, there is a substantial unmet need to diagnose various diseases effectively. The complexity of the different disease mechanisms and underlying symptoms of the patient population presents massive challenges in developing the early diagnosis tool and effective treatment. Machine learning (ML), an area of artificial intelligence (AI), enables researchers, physicians, and patients to solve some of these issues. Based on relevant research, this review explains how machine learning (ML) is being used to help in the early identification of numerous diseases. Initially, a bibliometric analysis of the publication is carried out using data from the Scopus and Web of Science (WOS) databases. The bibliometric study of 1216 publications was undertaken to determine the most prolific authors, nations, organizations, and most cited articles. The review then summarizes the most recent trends and approaches in machine-learning-based disease diagnosis (MLBDD), considering the following factors: algorithm, disease types, data type, application, and evaluation metrics. Finally, in this paper, we highlight key results and provides insight into future trends and opportunities in the MLBDD area. [ABSTRACT FROM AUTHOR]

Simple Summary: Early detection of malignant melanoma (MM) has the potential to significantly reduce morbidity and mortality as the thickness of the lesion is closely associated with prognosis. Artificial intelligence (AI) is a non-invasive technology that has the potential to aid clinicians in the early diagnosis of skin cancers, including melanoma. Performance metrics of machine-based AI have been shown to rival or improve upon clinician diagnosis. However, many studies have limited this scope to pre-build image databases that may not replicate real-world settings experienced in general practice. This systematic review aimed to report the performance of commercial or market-approved dermatoscopic systems with AI in the form of convolutional neural networks (CNNs) when tasked with classifying melanoma. The sensitivity and specificity of CNNs are highly varied and illustrate the necessity of clinician-to-patient interaction in the diagnosis process. Clinicians working in unison with AI show the most promise for better performance when classifying MM. Background: Cutaneous melanoma remains an increasing global public health burden, particularly in fair-skinned populations. Advancing technologies, particularly artificial intelligence (AI), may provide an additional tool for clinicians to help detect malignancies with a more accurate success rate. This systematic review aimed to report the performance metrics of commercially available convolutional neural networks (CNNs) tasked with detecting MM. Methods: A systematic literature search was performed using CINAHL, Medline, Scopus, ScienceDirect and Web of Science databases. Results: A total of 16 articles reporting MM were included in this review. The combined number of melanomas detected was 1160, and non-melanoma lesions were 33,010. The performance of market-approved technology and clinician performance for classifying melanoma was highly heterogeneous, with sensitivity ranging from 16.4 to 100.0%, specificity between 40.0 and 98.3% and accuracy between 44.0 and 92.0%. Less heterogeneity was observed when clinicians worked in unison with AI, with sensitivity ranging between 83.3 and 100.0%, specificity between 83.7 and 87.3%, and accuracy between 86.4 and 86.9%. Conclusion: Instead of focusing on the performance of AI versus clinicians for classifying melanoma, more consistent performance has been obtained when clinicians' work is supported by AI, facilitating management decisions and improving health outcomes. [ABSTRACT FROM AUTHOR]

Chassis system components such as dampers have a significant impact on vehicle stability, driving safety, and driving comfort. Therefore, monitoring and diagnosing the defects of these components is necessary. Currently, this task is based on the driver's perception of component defects in series production vehicles, even though model-based approaches in the literature exist. As we observe an increased availability of data in modern vehicles and advances in the field of deep learning, this paper deals with the analysis of the performance of Convolutional Neural Networks (CNN) for the diagnosis of automotive damper defects. To ensure a broad applicability of the generated diagnosis system, only signals of a classic Electronic Stability Control (ESC) system, such as wheel speeds, longitudinal and lateral vehicle acceleration, and yaw rate, were used. A structured analysis of data pre-processing and CNN configuration parameters were investigated in terms of the defect detection result. The results show that simple Fast Fourier Transformation (FFT) pre-processing and configuration parameters resulting in small networks are sufficient for a high defect detection rate. [ABSTRACT FROM AUTHOR]

This study proposes a Computer-Aided Diagnostic (CAD) system to diagnose subjects with autism spectrum disorder (ASD). The CAD system identifies morphological anomalies within the brain regions of ASD subjects. Cortical features are scored according to their contribution in diagnosing a subject to be ASD or typically developed (TD) based on a trained machine-learning (ML) model. This approach opens the hope for developing a new CAD system for early personalized diagnosis of ASD. We propose a framework to extract the cerebral cortex from structural MRI as well as identifying the altered areas in the cerebral cortex. This framework consists of the following five main steps: (i) extraction of cerebral cortex from structural MRI; (ii) cortical parcellation to a standard atlas; (iii) identifying ASD associated cortical markers; (iv) adjusting feature values according to sex and age; (v) building tailored neuro-atlases to identify ASD; and (vi) artificial neural networks (NN) are trained to classify ASD. The system is tested on the Autism Brain Imaging Data Exchange (ABIDE I) sites achieving an average balanced accuracy score of 97 ± 2 % . This paper demonstrates the ability to develop an objective CAD system using structure MRI and tailored neuro-atlases describing specific developmental patterns of the brain in autism. [ABSTRACT FROM AUTHOR]

Heart disease is a significant public health problem, and early detection is crucial for effective treatment and management. Conventional and noninvasive techniques are cumbersome, time-consuming, inconvenient, expensive, and unsuitable for frequent measurement or diagnosis. With the advance of artificial intelligence (AI), new invasive techniques emerging in research are detecting heart conditions using machine learning (ML) and deep learning (DL). Machine learning models have been used with the publicly available dataset from the internet about heart health; in contrast, deep learning techniques have recently been applied to analyze electrocardiograms (ECG) or similar vital data to detect heart diseases. Significant limitations of these datasets are their small size regarding the number of patients and features and the fact that many are imbalanced datasets. Furthermore, the trained models must be more reliable and accurate in medical settings. This study proposes a hybrid one-dimensional convolutional neural network (1D CNN), which uses a large dataset accumulated from online survey data and selected features using feature selection algorithms. The 1D CNN proved to show better accuracy compared to contemporary machine learning algorithms and artificial neural networks. The non-coronary heart disease (no-CHD) and CHD validation data showed an accuracy of 80.1% and 76.9%, respectively. The model was compared with an artificial neural network, random forest, AdaBoost, and a support vector machine. Overall, 1D CNN proved to show better performance in terms of accuracy, false negative rates, and false positive rates. Similar strategies were applied for four more heart conditions, and the analysis proved that using the hybrid 1D CNN produced better accuracy. [ABSTRACT FROM AUTHOR]

Artificial intelligence is highly regarded as the most promising future technology that will have a great impact on healthcare across all specialties. Its subsets, machine learning, deep learning, and artificial neural networks, are able to automatically learn from massive amounts of data and can improve the prediction algorithms to enhance their performance. This area is still under development, but the latest evidence shows great potential in the diagnosis, prognosis, and treatment of urological diseases, including bladder cancer, which are currently using old prediction tools and historical nomograms. This review focuses on highly significant and comprehensive literature evidence of artificial intelligence in the management of bladder cancer and investigates the near introduction in clinical practice. [ABSTRACT FROM AUTHOR]

The maintenance paradigm has evolved over the last few years and companies that want to remain competitive in the market need to provide condition-based maintenance (CBM). The diagnosis and prognosis of the health status of equipment, predictive maintenance (PdM), are fundamental strategies to perform informed maintenance, increasing the company's profit. This article aims to present a diagnosis and prognosis methodology using a hidden Markov model (HMM) classifier to recognise the equipment status in real time and a deep neural network (DNN), specifically a gated recurrent unit (GRU), to determine this same status in a future of one week. The data collected by the sensors go through several phases, starting by cleaning them. After that, temporal windows are created in order to generate statistical features of the time domain to better understand the equipment's behaviour. These features go through a normalisation to produce inputs for a feature extraction process, via a principal component analysis (PCA). After the dimensional reduction and obtaining new features with more information, a clustering is performed by the K-means algorithm, in order to group similar data. These clusters enter the HMM classifier as observable states. After training using the Baum–Welch algorithm, the Viterbi algorithm is used to find the best path of hidden states that represent the diagnosis of the equipment, containing three states: state 1—"State of Good Operation"; state 2—"Warning State"; state 3—"Failure State". Once the equipment diagnosis is complete, the GRU model is used to predict the future, both of the observable states as well as the hidden states coming out from the HMM. Thus, through this network, it is possible to directly obtain the health states 7 days ahead, without the necessity to run the whole methodology from scratch. [ABSTRACT FROM AUTHOR]

Large-scale datasets, which have sufficient and identical quantities of data in each class, are the main factor in the success of deep-learning-based classification models for vision tasks. A shortage of sufficient data and interclass imbalanced data distribution, which often arise in the medical domain, cause modern deep neural networks to suffer greatly from imbalanced learning and overfitting. A diagnostic model of diabetic retinopathy (DR) that is trained from such a dataset using supervised learning is severely biased toward the majority class. To enhance the efficiency of imbalanced learning, the proposal of this study is to leverage retinal fundus images without human annotations by self-supervised or semi-supervised learning. The proposed approach to DR detection is to add an auxiliary procedure to the target task that identifies DR using supervised learning. The added process uses unlabeled data to pre-train the model that first learns features from data using self-supervised or semi-supervised learning, and then the pre-trained model is transferred with the learned parameter to the target model. This wrapper algorithm of learning from unlabeled data can help the model gain more information from samples in the minority class, thereby improving imbalanced learning to some extent. Comprehensive experiments demonstrate that the model trained with the proposed method outperformed the one trained with only the supervised learning baseline utilizing the same data, with an accuracy improvement of 4~5%. To further examine the method proposed in this study, a comparison is conducted, and our results show that the proposed method also performs much better than some state-of-the-art methods. In the case of EyePaCS, for example, the proposed method outperforms the customized CNN model by 9%. Through experiments, we further find that the models trained with a smaller but balanced dataset are not worse than those trained with a larger but imbalanced dataset. Therefore, our study reveals that utilizing unlabeled data can avoid the expensive cost of collecting and labeling large-scale medical datasets. [ABSTRACT FROM AUTHOR]

In recent times, several machine learning models have been built to aid in the prediction of diverse diseases and to minimize diagnostic errors made by clinicians. However, since most medical datasets seem to be imbalanced, conventional machine learning algorithms tend to underperform when trained with such data, especially in the prediction of the minority class. To address this challenge and proffer a robust model for the prediction of diseases, this paper introduces an approach that comprises of feature learning and classification stages that integrate an enhanced sparse autoencoder (SAE) and Softmax regression, respectively. In the SAE network, sparsity is achieved by penalizing the weights of the network, unlike conventional SAEs that penalize the activations within the hidden layers. For the classification task, the Softmax classifier is further optimized to achieve excellent performance. Hence, the proposed approach has the advantage of effective feature learning and robust classification performance. When employed for the prediction of three diseases, the proposed method obtained test accuracies of 98%, 97%, and 91% for chronic kidney disease, cervical cancer, and heart disease, respectively, which shows superior performance compared to other machine learning algorithms. The proposed approach also achieves comparable performance with other methods available in the recent literature. [ABSTRACT FROM AUTHOR]

Diabetic retinopathy (DR) is a common fundus disease that leads to irreversible blindness, which plagues the working-age population. Automatic medical imaging diagnosis provides a non-invasive method to assist ophthalmologists in timely screening of suspected DR cases, which prevents its further deterioration. However, the state-of-the-art deep-learning-based methods generally have a large amount of model parameters, which makes large-scale clinical deployment a time-consuming task. Moreover, the severity of DR is associated with lesions, and it is difficult for the model to focus on these regions. In this paper, we propose a novel deep-learning technique for grading DR with only image-level supervision. Specifically, we first customize the model with the help of self-knowledge distillation to achieve a trade-off between model performance and time complexity. Secondly, CAM-Attention is used to allow the network to focus on discriminative zone, e.g., microaneurysms, soft/hard exudates, etc.. Considering that directly attaching a classifier after the Side branch will disrupt the hierarchical nature of convolutional neural networks, a Mimicking Module is employed that allows the Side branch to actively mimic the main branch structure. Extensive experiments are conducted on two benchmark datasets, with an AUC of 0.965 and an accuracy of 92.9% for the Messidor dataset and 67.96% accuracy achieved for the challenging IDRID dataset, which demonstrates the superior performance of our proposed method. [ABSTRACT FROM AUTHOR]

Epilepsy is a common neurological condition. The effects of epilepsy are not restricted to seizures alone. They comprise a wide spectrum of problems that might impair and reduce quality of life. Even with medication, 30% of epilepsy patients still have recurring seizures. An epileptic seizure is caused by significant neuronal electrical activity, which affects brain activity. EEG shows these changes as high-amplitude spiky and sluggish waves. Recognizing seizures on an electroencephalogram (EEG) manually by a professional neurologist is a time-consuming and labor-intensive process, hence an efficient automated approach is necessary for the identification of epileptic seizure. One technique to increase the speed and accuracy with which a diagnosis of epileptic seizures could be made is by utilizing computer-aided diagnosis systems that are built on deep neural networks, or DNN. This study introduces a fusion of recurrent neural networks (RNNs) and bi-directional long short-term memories (BiLSTMs) for automatic epileptic seizure identification via EEG signal processing in order to tackle the aforementioned informational challenges. An electroencephalogram's (EEG) raw data were first normalized after undergoing pre-processing. A RNN model was fed the normalized EEG sequence data and trained to accurately extract features from the data. Afterwards, the features were passed to the BiLSTM layers for processing so that further temporal information could be retrieved. In addition, the proposed RNN-BiLSTM model was tested in an experimental setting using the freely accessible UCI epileptic seizure dataset. Experimental findings of the suggested model have achieved avg values of 98.90%, 98.50%, 98. 20%, and 98.60%, respectively, for accuracy, sensitivity, precision, and specificity. To further verify the new model's efficacy, it is compared to other models, such as the RNN-LSTM and the RNN-GRU learning models, and is shown to have improved the same metrics by 1.8%, 1.69%, 1.95%, and 2.2% on using 5-fold. Additionally, the proposed method was compared to state-of-the-art approaches and proved to be a more accurate categorization of such techniques. [ABSTRACT FROM AUTHOR]

Artificial Intelligence (AI) is progressively remodeling our daily life. A large amount of information from "big data" now enables machines to perform predictions and improve our healthcare system. AI has the potential to reshape prostate cancer (PCa) management thanks to growing applications in the field. The purpose of this review is to provide a global overview of AI in PCa for urologists, pathologists, radiotherapists, and oncologists to consider future changes in their daily practice. A systematic review was performed, based on PubMed MEDLINE, Google Scholar, and DBLP databases for original studies published in English from January 2009 to January 2019 relevant to PCa, AI, Machine Learning, Artificial Neural Networks, Convolutional Neural Networks, and Natural-Language Processing. Only articles with full text accessible were considered. A total of 1008 articles were reviewed, and 48 articles were included. AI has potential applications in all fields of PCa management: analysis of genetic predispositions, diagnosis in imaging, and pathology to detect PCa or to differentiate between significant and non-significant PCa. AI also applies to PCa treatment, whether surgical intervention or radiotherapy, skills training, or assessment, to improve treatment modalities and outcome prediction. AI in PCa management has the potential to provide a useful role by predicting PCa more accurately, using a multiomic approach and risk-stratifying patients to provide personalized medicine. [ABSTRACT FROM AUTHOR]

The increasing availability of molecular data provided by next-generation sequencing (NGS) techniques is allowing improvement in the possibilities of diagnosis and prognosis in renal cancer. Reliable and accurate predictors based on selected gene panels are urgently needed for better stratification of renal cell carcinoma (RCC) patients in order to define a personalized treatment plan. Artificial intelligence (AI) algorithms are currently in development for this purpose. Here, we reviewed studies that developed predictors based on AI algorithms for diagnosis and prognosis in renal cancer and we compared them with non-AI-based predictors. Comparing study results, it emerges that the AI prediction performance is good and slightly better than non-AI-based ones. However, there have been only minor improvements in AI predictors in terms of accuracy and the area under the receiver operating curve (AUC) over the last decade and the number of genes used had little influence on these indices. Furthermore, we highlight that different studies having the same goal obtain similar performance despite the fact they use different discriminating genes. This is surprising because genes related to the diagnosis or prognosis are expected to be tumor-specific and independent of selection methods and algorithms. The performance of these predictors will be better with the improvement in the learning methods, as the number of cases increases and by using different types of input data (e.g., non-coding RNAs, proteomic and metabolic). This will allow for more precise identification, classification and staging of cancerous lesions which will be less affected by interpathologist variability. [ABSTRACT FROM AUTHOR]